Protective effect of purinergic agonist ATPγS against acute lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 2, 2008, Pages

  Kolosova, Irina A ^a   Mirzapoiazova, Tamara ^b   Moreno Vinasco, Liliana ^b   Sammani, Saad ^b   Garcia, Joe G N ^b   Verin, Alexander D ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Endothelial barrier; Endotoxin lipopolysaccharide; Inflammation; Mice

Indexed keywords

ADENOSINE; ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALBUMIN; CELL SURFACE RECEPTOR; DYE; ENDOTOXIN; EVANS BLUE; LIPOPOLYSACCHARIDE; PURINE DERIVATIVE; PURINERGIC P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIMIDINE DERIVATIVE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL JUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRAVASATION; FLUID BALANCE; INFLAMMATION; LUNG EDEMA; LUNG ENDOTHELIUM; LUNG FLUID; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MORBIDITY; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PERMEABILITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD-AIR BARRIER; BODY WEIGHT; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; PNEUMONIA; PURINES; RESPIRATORY DISTRESS SYNDROME, ADULT; WEIGHT LOSS;

EID: 39149089666     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00283.2007     Document Type: Article

References (31)

1. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: established and potential clinical applications. Drugs 58: 211-232, 1999.
2. Agteresch HJ, Dagnelie PC, van Der Gaast A, Stijnen T, Wilson JH. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 92: 321-328, 2000.
3. Ahmad S, Ahmad A, White CW. Purinergic signaling and kinase activation for survival in pulmonary oxidative stress and disease. Free Radic Biol Med 41: 29-40, 2006.
4. Bodin P, Burnstock G. Increased release of ATP from endothelial cells during acute inflammation. Inflamm Res 47: 351-354, 1998.
5. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112: 358-404, 2006.
6. Bucheimer RE, Linden J. Purinergic regulation of epithelial transport. J Physiol 555: 311-321, 2004.
7. Daemen MA, van't Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104: 541-549, 1999.
8. Davis IC, Sullender WM, Hickman-Davis JM, Lindsey JR, Matalon S. Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 286: L112-L120, 2004.
9. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97: 587-600, 2001.
10. Garcia JG, Schaphorst KL, Shi S, Verin AD, Hart CM, Callahan KS, Patterson CE. Mechanisms of ionomycin-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 273: L172-L184, 1997.
11. Geary C, Akinbi H, Korfhagen T, Fabre JE, Boucher R, Rice W. Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 289: L890-L895, 2005.
12. Gunduz D, Hirche F, Hartel FV, Rodewald CW, Schafer M, Pfitzer G, Piper HM, Noll T. ATP antagonism of thrombin-induced endothelial barrier permeability. Cardiovasc Res 59: 470-478, 2003.
13. Gunduz D, Kasseckert SA, Hartel FV, Aslam M, Abdallah Y, Schafer M, Piper HM, Noll T, Schafer C. Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells. Cardiovasc Res 71: 764-773, 2006.
14. Hasko G, Kuhel DG, Salzman AL, Szabo C. ATP suppression of interleukin-12 and tumour necrosis factor-α release from macrophages. Br J Pharmacol 129: 909-914, 2000.
15. Jacobson JR, Dudek SM, Singleton PA, Kolosova IA, Verin AD, Garcia JG. Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin. Am J Physiol Lung Cell Mol Physiol 291: L289-L295, 2006.
16. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106: 1311-1319, 2000.
17. Kellerman D, Evans R, Mathews D, Shaffer C. Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease. Adv Drug Deliv Rev 54: 1463-1474, 2002.
18. Kolosova IA, Mirzapoiazova T, Adyshev D, Usatyuk P, Romer LH, Jacobson JR, Natarajan V, Pearse DB, Garcia JG, Verin AD. Signaling pathways involved in adenosine triphosphate-induced endothelial cell barrier enhancement. Circ Res 97: 115-124, 2005.
19. Kuebler WM, Abels C, Schuerer L, Goetz AE. Measurement of neutrophil content in brain and lung tissue by a modified myeloperoxidase assay. Int J Microcirc Clin Exp 16: 89-97, 1996.
20. Leipziger J. Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 284: F419-F432, 2003.
21. i. Am J Physiol Heart Circ Physiol 276: H1892-H1901, 1999.
22. Novak I. ATP as a signaling molecule: the exocrine focus. News Physiol Sci 18: 12-17, 2003.
23. Pearson JD, Gordon JL. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281: 384-386, 1979.
24. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169: 1245-1251, 2004.
25. Plata-Salaman CR. Cytokine-induced anorexia. Behavioral, cellular, and molecular mechanisms. Ann NY Acad Sci 856: 160-170, 1998.
26. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
27. Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 31: 217-233, 2005.
28. Sartori C, Matthay MA. Alveolar epithelial fluid transport in acute lung injury: new insights. Eur Respir J 20: 1299-1313, 2002.
29. Satpathy M, Gallagher P, Jin Y, Srinivas SP. Extracellular ATP opposes thrombin-induced myosin light chain phosphorylation and loss of barrier integrity in corneal endothelial cells. Exp Eye Res 81: 183-192, 2005.
30. Schwiebert LM, Rice WC, Kudlow BA, Taylor AL, Schwiebert EM. Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol Cell Physiol 282: C289-C301, 2002.
31. Tiruppathi C, Malik AB, Del Vecchio PJ, Keese CR, Giaever I. Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function. Proc Natl Acad Sci USA 89: 7919-7923, 1992.